Abstract
Oral ulcerative lesion is a painful and debilitating condition, particularly for immunosuppressed patients undergoing chemothera-peutic/irradiation treatment. Their clinical management requires multiple drugs to be administered simultaneously. Current formula-tions available to patients require frequent dosing, leading to poor compliance and suboptimal clinical outcomes. In this study, we prepared wheat germ agglutinin (WGA)-conjugated liposomes (WGA- liposomes) to serve as bioadhesive drug carriers that can encapsulate various classes of drugs, rapidly bind to oral epithelial cells within minutes, and stay on the cells to provide sustained, localized drug release for days. Fluorescence binding studies found a significant increase (p<0.05) in the binding of WGA- lipo-somes to oral cells in as short an incubation time as 1min compared to non- conjugated liposomes. WGA- liposomes encapsulating a model drug amoxicillin showed sustained in vitro drug release, and the released drugs provided potent antimicrobial activity against Streptococcus mutans in an oral epithelia-bacteria co-culture system. Exocytosis studies confirmed that the WGA- lipo-somes stayed within the oral cells for 48h, after which the cells completely removed the liposomes. Moreover, cell viability studies showed that there was a significant reduction in oral cell damage when the bacteria infected cells were treated with the amoxicillin loaded WGA- liposomes compared to the untreated controls. These results point to the great potential of the lectin- conjugated liposomes as cell-binding drug delivery systems to achieve localized, sustained drug release for the management of oral ulcerative lesions and other related complications.

This publication has 43 references indexed in Scilit: